Search

Showing results for: AUTHOR - Burge, M

Found: 12 results

Simulating progression-free and overall survival for first-line doublet chemotherapy with or without bevacizumab in metastatic colorectal cancer patients based on real-world registry data Pharmacoeconomics - 2020-11 Degeling, K; Wong, HL; Koffijberg, H; Jalali, A; Shapiro, J; Kosmider, S; Wong, R; Lee, B; Burge, M; Tie, J; Yip, D; Nott, L; Khattak, A; Lim, S; Caird, S; Gibbs, P; IJzerman M
Link to Publisher's Version
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer Current Problems in Cancer - 2020-08-14 Prasanna, T; Wong, R; Price, T; Shapiro, J; Tie, J; Wong, HL; Nott, L; Roder, D; Lee, M; Kosmider, S; Jalali, A; Burge, M; Padbury, R; Maddern, G; Carruthers, S; Moore, J; Sorich, M; Karapetis, CS; Gibbs, P; Yip, D
Link to Publisher's Version
Real-world treatment and outcomes of metastatic colorectal cancer patients with a poor or very poor performance status Clinical Colorectal Cancer - 2020-08-12 Travers, A; Jalali, A; Begbie, S; Semira, C; Kosmider, S; Ananda, S; Wong, R; Lee, M; Shapiro, J; Burge, M; Yip, D; Torres, J; Ma, B; Nott, L; Dean, A; Tie, J; Khattak, A; Lim, S; Wong, HL; Gibbs, P
Link to Publisher's Version
Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in Australia Asia-Pacific Journal of Clinical Oncology - 2020-04 Price, T; Burge, M; Chantrill, L; Gibbs, P; Pavlakis, N; Shapiro, J; Sjoquist, K
Link to Publisher's Version
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localised pancreatic cancer Annals of Oncology - 2019-09-01 Lee, B; Lipton, L; COHEN, J; Tie, J; Javed, AA; Li, L; Goldstein, D; Burge, M; Cooray, P; Nagrial, A; Tebbutt, NC; Thomson, B; Nikfarjam, M; Harris, M; Haydon, A; Lawrence, B; Wm Tai, D; Simons, K; Lennon, AM; Wolfgang, CL; Tomasetti, C; Papadopoulos, N; Kinzler, KW; Vogelstein, B; Gibbs, P
Link to Publisher's Version
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence? Internal Medicine Journal - 2019-08 Semira, C; Wong, HL; Field, K; Lee, M; Lee, B; Nott, L; Shapiro, J; Wong, R; Tie, J; Tran, B; Richardson, G; Zimet, A; Lipton, L; Tamjid, B; Burge, M; Ma, B; Johns, J; Harold, M; Gibbs, P
Link to Publisher's Version Download PDF
Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survival Asia Pacific Journal of Clinical Oncology - 2019-02-13 Mendis, S; Beck, S; Lee, B; Lee, M; Wong, R; Kosmider, S; Shapiro, J; Yip, D; Steel, S; Nott, L; Jennens, R; Lipton, L; Burge, M; Field, K; Ananda, S; Wong, HL; Gibbs, P
Link to Publisher's Version
Previous bevacizumab and efficacy of later anti-epidermal growth factor receptor antibodies in metastatic colorectal cancer: results from a large international registry Clinical Colorectal Cancer - 2018-09 Burge, M; Semira, C; Lee, B; Lee, M; Kosmider, S; Wong, R; Shapiro, J; Ma, B; Dean, AP; Zimet, AS; Steel, SA; Lok, SW; Torres, J; Eastgate, M; Wong, HL; Gibbs, P
Link to Publisher's Version
Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis Expert Review of Anticancer Therapy - 2018-02-26 Tang, M; Price, TJ; Shapiro, J; Gibbs, P; Haller, DG; Arnold, D; Peeters, M; Segelov, E; Roy, A; Tebbutt, N; Pavlakis, N; Karapetis, C; Burge, M
Link to Publisher's Version
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study Gut - 2018-02-02 Tie, J; Cohen, JD; Wang, Y; Li, L; Christie, M; Simons, K; Elsaleh, H; Kosmider, S; Wong, R; Yip, D; Lee, M; Tran, B; Rangiah, D; Burge, M; Goldstein, D; Singh, M; Skinner, I; Faragher, I; Croxford, M; Bampton, C; Haydon, A; Jones, IT; SKarapetis C; Price, T; Schaefer, MJ; Ptak, J; Dobbyn, L; Silliman, N; Kinde, I; Tomasetti, C; Papadopoulos, N; Kinzler, K; Volgestein, B; Gibbs, P
Link to Publisher's Version
Targeted therapy for metastatic colorectal cancer Expert Review of Anticancer Therapy - 2018 Price, TJ; Tang, M; Gibbs, P; Haller, DG; Peeters, M; Arnold, D; Segelov, E; Roy, A; Tebbutt, N; Pavlakis, N; Karapetis, C; Burge, M; Shapiro, J
Link to Publisher's Version Download Author Manuscript
The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort study Asia Pac J Clin Oncol - 2016-11-25 Lee, B; Wong, HL; Tacey, M; Tie, J; Wong, R; Lee, M; Nott, L; Shapiro, J; Jennens, R; Turner, N; Tran, B; Ananda, S; Yip, D; Richardson, G; Parente, P; Lim, L; Stefanou, G; Burge, M; Iddawela, M; Power, J; Gibbs, P
Link to Publisher's Version

An error has occurred. This application may no longer respond until reloaded. Reload 🗙